[ET Net News Agency, 14 July 2021] ALPHAMAB-B (09966) rose 9.81% to HK$28.55.
It hits an intra-day high of HK$28.7, hitting a historical high, and an intra-day low of
HK$25.8. The total shares traded was 2.81 million, with a value of HK$76.99m. The active
buy/sell ratio is 81:19, with net buying turnover of HK$46.87m. CHINA INT'L CAPITAL CORP
HK accounts for greatest net responsive buying turnover of HK$2.45m, with volume weighted
average price of HK$26.7. CHINA INNOVATION MARKET SER accounts for greatest net responsive
selling turnover of HK$14.02m, with volume weighted average price of HK$27.436. The stock
has risen a combined 21.49% over the past 4 consecutive trading days.
The Hang Seng Index now fell 130 points, or 0.47% to 27,832; the Hang Seng China
Enterprises Index now fell 34 points, or 0.34% to 10,078; the Hang Seng TECH Index now
rose 34 points, or 0.45% to 7,693; with an overall turnover of HK$46.69b.
The SSE Composite Index now fell 30 points, or 0.86% to 3,535, with an overall turnover
of RMB216.12b.
The SZSE Component Index now fell 97 points, or 0.64% to 15,091, with an overall
turnover of RMB155.91b.
Basic Information
-------------------------------------------
Nominal 28.550 % Chg +9.81%
High 28.700 Low 25.800
Shares Tr 2.81m Turnover 76.99m
10-D SMA 25.250 %H.V 57.592
20-D SMA 24.225 VWAP 27.444
50-D SMA 21.012 RSI14 72.026
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 81:19, with net buying
turnover of HK$46.87m, rising a combined 21.49% over the past 4 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
ALPHAMAB-B (09966) 28.55 +9.81
JACOBIO-B (01167) 21.65 -6.07
GENSCRIPT BIO (01548) 39.60 +5.60
INNOVENT BIO (01801) 88.45 +2.25
JXR (01951) 16.78 +4.22
BRII-B (02137) 22.00 -4.14
WUXI BIO (02269) 140.80 +7.24
TIGERMED (03347) 180.50 +2.04
CANSINOBIO-B (06185) 325.80 +2.71
HAOHAI BIOTEC (06826) 108.70 +4.52
-------------------------------------------------
(ed)